Device company HDL Therapeutics eyes public listing in $480m SPAC deal

Device company HDL Therapeutics eyes public listing in $480m SPAC deal

Submitted by admin on August 14, 2023 - 10:20am
Source: 
Pharmaphorum
News Tags: 
Medtech
SPAC
HDL Therapeutics
NASDAQ
atherosclerotic plaques
Headline: 
Device company HDL Therapeutics eyes public listing in $480m SPAC deal
snippet: 

US medical device company HDL Therapeutics is aiming to list on the Nasdaq via a merger with Swiftmerge Acquisition, a special purpose acquisition company (SPAC).

Do Not Allow Advertisers to Use My Personal information